The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Maslov L.N.
Research Institute of Cardiology, Tomsk, Russia
Tsibulnikov S.Yu.
Research Institute of Cardiology, Tomsk, Russia;
National Research Tomsk Polytechnic University, Tomsk, Russia
Tsepokina A.V.
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
Khutornaya M.V.
Research Institute for Complex Problems of Cardiovascular Diseases, Kemerovo, Russia
Kutikhin A.G.
Division of Experimental and Clinical Cardiology, Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Boulevard 6, Kemerovo, 650002, Russian Federation
Tsibulnikova M.R.
Research Institute of Cardiology, Tomsk, Russia;
National Research Tomsk Polytechnic University, Tomsk, Russia
Basalay M.V.
Republican Research and Practical Center of Cardiology, Minsk, Belarus
Mrochek A.G.
Republican Scientific and Practical Center «Cardiology» Ministry of Health Republic of Belarus, 110 B, R. Luxembourg street, 220036, Minsk, Belarus
Neuroprotective and nephroprotective effects of remote postconditioning: Prospects for clinical use
Journal: Therapeutic Archive. 2016;88(8): 121‑126
Views: 2073
Downloaded: 473
To cite this article:
Maslov LN, Tsibulnikov SYu, Tsepokina AV, et al. . Neuroprotective and nephroprotective effects of remote postconditioning: Prospects for clinical use. Therapeutic Archive.
2016;88(8):121‑126. (In Russ.)
https://doi.org/10.17116/terarkh2016888121-126
The results of experimental and clinical studies strongly suggest that remote ischemic preconditioning (RIP) has no neuroprotective effect during cardiac surgery performed under extracorporeal circulation. Remote preconditioning (RP) has no neuroprotective effect in hemorrhagic stroke. A randomized multicenter study is needed to evaluate the efficiency RIP in patients with ischemic stroke. RP reduces the severity of ischemia/reperfusion kidney injury during transplantation. RIP has been established to prevent contrast-induced nephropathy. There is a need for a multicenter trial to evaluate the efficiency of RIP in patients with abdominal aortic aneurysm repair. Analysis of the presented data indicates that RIP fails to prevent cardiorenal syndrome in infants and children during cardiac surgery. The data available in the literature on the capacity of RIP to provide nephroprotective effect in patients after coronary artery bypass surgery are discordant and indicative of the advisability of a multicenter study.
Keywords:
Authors:
Maslov L.N.
Research Institute of Cardiology, Tomsk, Russia
Tsibulnikov S.Yu.
Research Institute of Cardiology, Tomsk, Russia;
National Research Tomsk Polytechnic University, Tomsk, Russia
Tsepokina A.V.
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
Khutornaya M.V.
Research Institute for Complex Problems of Cardiovascular Diseases, Kemerovo, Russia
Kutikhin A.G.
Division of Experimental and Clinical Cardiology, Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Boulevard 6, Kemerovo, 650002, Russian Federation
Tsibulnikova M.R.
Research Institute of Cardiology, Tomsk, Russia;
National Research Tomsk Polytechnic University, Tomsk, Russia
Basalay M.V.
Republican Research and Practical Center of Cardiology, Minsk, Belarus
Mrochek A.G.
Republican Scientific and Practical Center «Cardiology» Ministry of Health Republic of Belarus, 110 B, R. Luxembourg street, 220036, Minsk, Belarus
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.